Specifically, patients with lymphoma, colorectal cancer, and hepatocellular carcinoma demonstrated significantly higher frequencies of aPL than healthy controls, with IgM aCL and IgM anti-β2-GPI showing highest prevalence. Here, APOH is linked to hepatocellular carcinoma.